Class information for:
Level 1: ELGODIPINE//NISOLDIPINE//GALLOPAMIL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1148 2723 30.8 51%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
708 12194 CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ELGODIPINE Author keyword 21 90% 0% 9
2 NISOLDIPINE Author keyword 9 22% 1% 36
3 GALLOPAMIL Author keyword 7 28% 1% 20
4 NISOLDIPINE COAT CORE Author keyword 6 100% 0% 4
5 ANTIANGINA Author keyword 3 100% 0% 3
6 YM 16151 4 Author keyword 3 100% 0% 3
7 CAS 63675 72 9 Author keyword 3 60% 0% 3
8 ONCE DAILY SUSTAINED RELEASE FORMULATION Author keyword 2 67% 0% 2
9 CAS 54527 84 3 Author keyword 1 100% 0% 2
10 CONTROLLED DELIVERY DILTIAZEM Author keyword 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ELGODIPINE 21 90% 0% 9 Search ELGODIPINE Search ELGODIPINE
2 NISOLDIPINE 9 22% 1% 36 Search NISOLDIPINE Search NISOLDIPINE
3 GALLOPAMIL 7 28% 1% 20 Search GALLOPAMIL Search GALLOPAMIL
4 NISOLDIPINE COAT CORE 6 100% 0% 4 Search NISOLDIPINE+COAT+CORE Search NISOLDIPINE+COAT+CORE
5 ANTIANGINA 3 100% 0% 3 Search ANTIANGINA Search ANTIANGINA
6 YM 16151 4 3 100% 0% 3 Search YM+16151+4 Search YM+16151+4
7 CAS 63675 72 9 3 60% 0% 3 Search CAS+63675+72+9 Search CAS+63675+72+9
8 ONCE DAILY SUSTAINED RELEASE FORMULATION 2 67% 0% 2 Search ONCE+DAILY+SUSTAINED+RELEASE+FORMULATION Search ONCE+DAILY+SUSTAINED+RELEASE+FORMULATION
9 CAS 54527 84 3 1 100% 0% 2 Search CAS+54527+84+3 Search CAS+54527+84+3
10 CONTROLLED DELIVERY DILTIAZEM 1 100% 0% 2 Search CONTROLLED+DELIVERY+DILTIAZEM Search CONTROLLED+DELIVERY+DILTIAZEM

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTRAVENOUS NISOLDIPINE 33 100% 0% 13
2 EXERTIONAL ANGINA 18 83% 0% 10
3 SUSTAINED RELEASE DILTIAZEM 15 67% 1% 14
4 HIGH DOSE DILTIAZEM 7 64% 0% 7
5 INCREASED EXERCISE TOLERANCE 6 80% 0% 4
6 ONCE DAILY DILTIAZEM 5 55% 0% 6
7 SLOW RELEASE NICARDIPINE 4 67% 0% 4
8 CHANNEL BLOCKING AGENTS 4 22% 1% 17
9 SLOW RELEASE NIFEDIPINE 4 56% 0% 5
10 BLOCKER NISOLDIPINE 3 100% 0% 3

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina 1999 141 97 55%
DILTIAZEM - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE 1990 146 268 45%
DRUG-THERAPY - COMBINED BETA-ADRENERGIC AND CALCIUM-ENTRY BLOCKADE IN ANGINA-PECTORIS 1989 93 101 70%
PATHOPHYSIOLOGICAL MECHANISMS UNDERLYING THE ADVERSE-EFFECTS OF CALCIUM-CHANNEL BLOCKING-DRUGS IN PATIENTS WITH CHRONIC HEART-FAILURE 1989 103 89 39%
NICARDIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY, IN THE TREATMENT OF ANGINA-PECTORIS, HYPERTENSION AND RELATED CARDIOVASCULAR DISORDERS 1987 144 168 58%
Anomalies in the dosing of diltiazem 2000 10 34 74%
CALCIUM-ANTAGONISTS IN ELDERLY AND BLACK HYPERTENSIVE PATIENTS - THERAPEUTIC CONTROVERSIES 1991 23 42 81%
CALCIUM-ANTAGONISTS IN THE TREATMENT OF ISCHEMIC-HEART-DISEASE - MYOCARDIAL-INFARCTION 1994 26 29 59%
SUSTAINED-RELEASE NIFEDIPINE FORMULATIONS - AN APPRAISAL OF THEIR CURRENT USES AND PROSPECTIVE ROLES IN THE TREATMENT OF HYPERTENSION, ISCHEMIC-HEART-DISEASE AND PERIPHERAL VASCULAR DISORDERS 1991 55 203 35%
DILTIAZEM - 10 YEARS OF CLINICAL-EXPERIENCE IN THE TREATMENT OF HYPERTENSION 1995 40 93 42%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 HLTH SCI CARDIOVASC INTERNAL MED 1 50% 0.0% 1
2 INVEST CLIN NANCY 1 50% 0.0% 1
3 J HILLIS MILLER HLTH PHARM 1 50% 0.0% 1
4 CARDIOVASC MED Y 0 33% 0.0% 1
5 5000 E BELANGER ST 0 17% 0.1% 2
6 HALLSTROM CARDIOL 0 25% 0.0% 1
7 RECH SERV NEPHROL 0 25% 0.0% 1
8 OSPED SAN VITO 0 20% 0.0% 1
9 UNITA RIC CLIN 0 20% 0.0% 1
10 9500 EUCLID AVE 0 17% 0.0% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000232068 FELODIPINE//NORMOTENSIVE VOLUNTEERS//ARANIDIPINE
2 0.0000215067 NORVERAPAMIL//CLIN PHARMACOL GERIATR MED//S VERAPAMIL
3 0.0000213255 DIHYDROPYRIDINE TYPE CALCIUM CHANNEL BLOCKER//ETAFTORON//HOSP XIAMEN AFFILIATED 1
4 0.0000211667 DESACETYLDILTIAZEM//DEACETYLDILTIAZEM//CAS 42399 41 7
5 0.0000186964 ISRADIPINE//CAS 75695 93 1//DENSITY DEPENDENT GROWTH INHIBITION
6 0.0000156246 AMLODIPINE//DILTIAZEM CR//BESYLATE
7 0.0000143826 MEBUDIPINE//BARNIDIPINE HYDROCHLORIDE//BARNIDIPINE
8 0.0000138287 PRANIDIPINE//OPC 13340//CAS 99522 79 9
9 0.0000115042 BEPRIDIL//CAS 117241 46 0//REVUE DE MEDECINE
10 0.0000097166 CD 832//KT 362//HEART RATE DEPENDENCY